Condensed consolidated and combined statements of cash flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Operating activities
Net loss	$ (15,936,517)	$ (5,189,256)
Non-cash items and reclassifications:
Amortization	115,490	45,198
Financing costs	319,635
Fees and penalty on bank loan repayment	100,000
Gain on sale of equipment	(5,312)	(124,353)
Amortization and extinguishment of remaining discount on preferred stock upon conversion of preferred stock	1,884,233	265,650
Change in fair value of derivative liabilities	(957,818)	(972,757)
Stock-based compensation	585,111	255,318
Stock-based purchase of patent rights	186,356
Foreign exchange loss and other	107,754
Changes in operating assets and liabilities:
Accounts and other amounts receivable	(48,297)	(5,547)
Prepayments and deposits	(125,082)	(35,801)
Accounts payable and accrued liabilities	2,982,940	1,678,451
Cash used in operating activities	(10,791,507)	(4,083,097)
Investing activities
Purchase of investments	(36,474,883)
Proceeds from maturity of investments	6,920,438
Purchase of property and equipment	(86,322)	(7,233)
Sale of property and equipment	16,534	181,618
Cash provided by (used in) investing activities	(29,624,233)	174,385
Financing activities
Repayment of bank loan, fees and penalty	(2,600,000)
Preferred stock (redemption) issued	(590)	17,999,968
Share issue costs		(223,910)
Proceeds from exercise of stock options	460
Initial public offering of common shares	53,130,000
Initial public offering costs	(5,251,288)
Cash provided by financing activities	45,278,582	17,776,058
Increase in cash and cash equivalents during the period	4,862,842	13,867,346
Cash and cash equivalents, beginning of period	11,006,392	2,000,539
Cash and cash equivalents, end of period	15,869,234	15,867,885
Supplemental disclosure of cash flow information:
Interest paid	31,719
Interest received	80,167
Non-cash financing activities:
Accrued offering costs		$ 25,000